Sep
27
Middletown, DE — (TechSonian) — 09/27/2013 –VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Orexigen Therapeutics, Inc (NASDAQ:OREX), Steel Dynamics, Inc (NASDAQ:STLD), Array Biopharma Inc (NASDAQ:ARRY), Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL)
Orexigen Therapeutics, Inc (NASDAQ:OREX) opened the session at $6.28, trading in a range of 6.28 – $6.54, and closed at $0.276. The stock showed a positive performance of 3.50% in the last trading session. The stock traded on a volume of 1.26 million shares and the average volume of the stock remained 961,416.00 shares. Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body’s efforts to compensate for weight loss.
Will OREX Continue To Move Higher? Find Out Here
Steel Dynamics, Inc (NASDAQ:STLD) traded 1.24 million shares in the last business day while the average volume of the stock remained 2.12 million shares. The 52 week range of the stock remained $10.99 – $17.57. The stock showed a positive movement of 0.84% to end at $16.76. Steel Dynamics, Inc. is a steel producer and metals recycler in the United States. The Company operates in three segments: steel operations, metals recycling and ferrous resources operations, and steel fabrication operations. As of December 31, 2012, the Company estimated annual steelmaking capability of 6.4 million tons and actual recycling volumes.
For How Long STLD will fight for Profitability? Read This Trend Analysis report
Array Biopharma Inc (NASDAQ:ARRY) reported 1.23 million shares were exchanged during the last trade, while the average volume is about 1.60 million shares. The stock dropped -0.50% and finished the day at $5.97. The beta of the stock is recorded at 1.75. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company’s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.
Why Should Investors Buy ARRY After the Recent Fall? Just Go Here and Find Out
Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) the stock advanced 1.89% and finished the session at $9.72. Traded with volume of 1.22 million shares in the prior session and the average volume of the stock remained 613,158.00 shares. Grupo Financiero Galicia SA is an Argentina-based financial services holding company. Banco de Galicia y Buenos Aires SA is the Company’s major asset, which provides a range of financial products and services to large corporations, small and medium sized companies (SMEs), and individuals. The Company operates through numerous subsidiaries,
Will GGAL Continue To Move Higher? Find Out Here
About VipStockReports.com:
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the ‘Next Hot Penny Stock’ with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
Disclaimer:
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Open all references in tabs: [1 – 6]
Comments
Leave a Reply
You must be logged in to post a comment.